FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Hormuz choke point persists as Iran halts oil traffic despite Trump ceasefire

DoorDash data offers snapshot of economy voters are feeling ahead of midterms

Putin issues a decree calling for a ceasefire in fighting for Orthodox Easter holiday

Artemis II nears end of historic mission with splashdown off California coast

Trump blasts Biden admin for releasing illegal immigrant now charged in fatal hammer attack on Florida mother

Iran peace talks give JD Vance an opening in 2028 race

Mahmoud Khalil loses appeal to dismiss deportation case

Coast Guard seizes over 4,500 pounds of cocaine worth $34M from suspected narco-terrorist vessel on Easter

ICE says more criminal migrants arrested on 1-year anniversary of program to support victims of migrant crime

Supreme Court blocks candidate after alleged GOP infiltration scheme exposed

Child among 4 dead as accused arsonist allegedly drank beer during chaos

Neighbor fatally shoots alleged gunman after 2 women shot in domestic dispute

Melania Trump’s forceful Epstein denial draws bipartisan support from lawmakers

Fellow Democrats Are Now Calling Out Eric Swalwell Over ‘Very Troubling’ Accusations

Michael Moore Defends Iran, Slams US for Bombing Japan in WWII in Deranged Rant: ‘We’re the Bad Guys!’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”